Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Days.
The item "Days-of-Sales-Outstanding" stands at 98.19 days as of 09/30/2025.
As of the end of Eli Lilly and Company's third quarter, the item "Days of Sales Outstanding" stands at 98.19 Days. This represents an increase of 1.37 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.39 percent compared to the value the year prior.
The 1 year change in percent is -5.39.
The 3 year change in percent is -1.46.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Days of Sales Outstanding | 486,508,953,600.00 |
![]() | AbbVie Inc - Days of Sales Outstanding | 399,570,305,024.00 |
![]() | Roche Holding AG - Days of Sales Outstanding | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Days of Sales Outstanding | 280,205,508,085.11 |
![]() | Novartis AG - Days of Sales Outstanding | 255,096,620,580.91 |